151.98 -0.05 -0.03%
Official Close 3/17/2023 NYSE

Is AmerisourceBergen stock a Buy, Sell or Hold? AmerisourceBergen stock has received a consensus rating of buy. The average rating score is and is based on 18 buy ratings, 13 hold ratings, and 0 sell ratings.
What was the 52-week low for AmerisourceBergen stock? The low in the last 52 weeks of AmerisourceBergen stock was 135.14. According to the current price, AmerisourceBergen is 112.49% away from the 52-week low.
What was the 52-week high for AmerisourceBergen stock? The high in the last 52 weeks of AmerisourceBergen stock was 174.60. According to the current price, AmerisourceBergen is 87.07% away from the 52-week high.
What are analysts forecasts for AmerisourceBergen stock? The 31 analysts offering price forecasts for AmerisourceBergen have a median target of 166.48, with a high estimate of 201.00 and a low estimate of 130.00. The median estimate represents a 91.31 difference from the last price of 152.02.

AmerisourceBergen Stock Snapshot

151.95
Bid
5,400.00
Bid Size
152.04
Ask
10,000.00
Ask Size
3/17/2023
Date
4:15 PM
Time
1.47 M
Volume
152.05
Prev. Close
152.55
Open
30.27 B
Market Cap
202.26 M
Number of Shares
150.51
Day Low
152.55
Day High
152.02
135.14
52 Week Low
174.60
52 Week High
152.02
1.96
Dividend
1.31
Dividend Yield
12.18
P/E Ratio
83.02
Free Float in %
11.63
EPS 2023
4.78
Book Value per Share
13.44
Cash Flow per Share

AmerisourceBergen Historical Prices

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

AmerisourceBergen Analyst Data

Total Analysts: 31
Buy Ratings: 18 Neutral Ratings: 13 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 130.00 Median: 166.48 Highest: 201.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

AmerisourceBergen Analyst Opinions

02/02/23 Mizuho
Maintained Hold $170
02/02/23 Baird Patrick & Co
Maintained Buy $201
01/31/23 UBS
Maintained Buy $190
01/31/23 Evercore
Maintained Buy $185
01/12/23 Argus Research Company
Maintained Buy $190
01/11/23 Baird Patrick & Co
Maintained Buy $199
11/22/22 Credit Suisse
Maintained Buy $182
10/18/22 Cowen and Company, LLC
Maintained Buy $169
10/11/22 Bank of America Merrill Lynch
Upgraded to Buy $169
08/22/22 Morgan Stanley
Maintained Hold $176
08/04/22 Credit Suisse
Maintained Buy $175
07/20/22 Argus Research Company
Maintained Buy $170
07/11/22 Evercore
Downgraded to Hold $150
06/13/22 UBS
Maintained Buy $174
06/09/22 Cowen and Company, LLC
Maintained Buy $170
06/07/22 Deutsche Bank
Upgraded to Buy $178
05/27/22 Morgan Stanley
Maintained Hold $175
05/26/22 Barclays Capital
Upgraded to Buy $182
05/25/22 Deutsche Bank
Maintained Hold $167
05/05/22 Deutsche Bank
Maintained Hold $168
05/05/22 Mizuho
Maintained Hold $162
04/12/22 Morgan Stanley
Downgraded to Hold $178
02/03/22 Mizuho
Maintained Hold $139
01/11/22 Barclays Capital
Maintained Hold $152
12/17/21 Morgan Stanley
Maintained Buy $142
11/12/21 Deutsche Bank
Maintained Hold $153
11/08/21 Credit Suisse
Maintained Buy $145
11/05/21 Barclays Capital
Maintained Hold $135
08/31/21 Morgan Stanley
Maintained Buy $141
08/05/21 Credit Suisse
Maintained Buy $144
05/06/21 Barclays Capital
Maintained Hold $130

AmerisourceBergen Estimates* in USD

  2023 2024 2025 2026 2027
Revenue 252,046 265,696 280,613 297,979 315,690
Dividend 1.96 2.02 2.09 - -
Dividend Yield (in %) 1.31 % 1.35 % 1.40 % - -
EPS 11.63 12.60 13.70 15.24 16.03
P/E Ratio 13.21 12.20 11.22 10.09 9.59
EBIT 3,185 3,438 3,638 3,899 4,226
EBITDA 3,724 3,920 4,146 4,726 5,112
Net Profit 2,368 2,531 2,678 3,016 3,293
Net Profit Adjusted 2,392 2,550 2,706 3,016 3,293
Pre-Tax Profit 2,976 3,186 3,366 3,782 4,128
Net Profit (Adjusted) 2,852 3,221 3,385 - -
EPS (Non-GAAP) ex. SOE 11.63 12.60 13.70 15.24 16.03
EPS (GAAP) 10.60 11.88 13.10 13.80 16.11
Gross Income 8,676 9,148 9,643 10,104 10,658
Cash Flow from Investing -1,531 -473 -484 - -
Cash Flow from Operations 2,587 3,182 3,377 3,550 4,135
Cash Flow from Financing -1,436 -1,610 -1,522 -500 0
Cash Flow per Share 13.44 18.87 18.71 - -
Free Cash Flow 2,124 2,678 2,866 2,885 3,403
Free Cash Flow per Share 7.31 12.62 14.02 - -
Book Value per Share 4.78 12.19 20.22 - -
Net Debt 3,072 2,016 1,223 - -
Research & Development Exp. - - - - -
Capital Expenditure 1,172 1,203 1,261 666 732
Selling, General & Admin. Exp. 5,090 5,298 5,528 - -
Shareholder’s Equity 1,091 2,089 3,200 3,400 5,958
Total Assets 58,388 60,425 63,429 67,455 72,720
  Previous Quarter Current Quarter
ending 03/31/23
Next Quarter
ending 06/30/23
Current Year
ending 09/30/23
Next Year
ending 09/30/24
Earnings Estimates
No. of Analysts - 14 14 15 14
Average Estimate - 3.308 USD 2.813 USD 11.635 USD 12.596 USD
Year Ago - 3.220 USD 2.620 USD 11.030 USD 11.635 USD
Publish Date - 2/1/2023 5/3/2023 - -
Revenue Estimates
No. of Analysts - 10 10 13 12
Average Estimate - 60,408 USD 63,344 USD 252,046 USD 265,696 USD
Year Ago - 57,719 USD 60,065 USD 238,587 USD 252,046 USD
Publish Date - 2/1/2023 5/3/2023 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

AmerisourceBergen Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
COLLIS STEVEN H 03/13/2023 10,499.00 257,967.00 150.00 Sell No
COLLIS STEVEN H 03/13/2023 10,499.00 268,466.00 77.53 Buy No
Battaglia Silvana 03/08/2023 359.00 11,704.45 150.00 Sell No
Miller Redonda 03/08/2023 1,334.00 1,562.00 n/a Buy No
McGee Henry Wadsworth III 03/08/2023 1,334.00 20,479.00 n/a Buy No
DURCAN DERMOT MARK 03/08/2023 1,667.00 18,730.00 n/a Buy No
HYLE KATHLEEN W 03/08/2023 1,334.00 21,970.00 n/a Buy No
NALLY DENNIS M 03/08/2023 1,334.00 8,730.00 n/a Buy No
GOCHNAUER RICHARD W 03/08/2023 1,334.00 26,326.00 n/a Buy No
Battaglia Silvana 03/08/2023 1,211.00 12,063.45 n/a Buy No
Kim Lorence H. 03/08/2023 1,334.00 1,892.00 n/a Buy No
GREENBERG LON R 03/08/2023 1,334.00 24,879.00 n/a Buy No
McGee Henry Wadsworth III 03/04/2023 2,012.00 15,014.00 n/a Buy No
NALLY DENNIS M 03/04/2023 2,012.00 4,605.00 n/a Buy No
HYLE KATHLEEN W 03/04/2023 2,012.00 17,845.00 n/a Buy No
Clark Gina 02/28/2023 1,838.00 26,733.00 156.22 Sell No
Clark Gina 02/28/2023 86.00 28,571.00 156.19 Sell No
COLLIS STEVEN H 02/13/2023 10,499.00 257,967.00 159.28 Sell No
COLLIS STEVEN H 02/13/2023 10,499.00 268,466.00 77.53 Buy No
Krikorian Lazarus 02/06/2023 5,711.00 18,732.00 155.82 Sell No
Campbell Elizabeth S 02/02/2023 1,486.00 16,088.41 156.73 Sell No
Krikorian Lazarus 02/02/2023 1,683.00 24,325.00 156.73 Sell No
Campbell Elizabeth S 02/02/2023 4,668.00 17,574.41 n/a Buy No
Krikorian Lazarus 02/02/2023 5,835.00 26,008.00 n/a Buy No
Miller Redonda 01/31/2023 228.00 228.00 n/a Buy No

AmerisourceBergen Dividend Calendar

Date Name Dividend *yield Currency
2022 AmerisourceBergen Corp. 1.84 1.36 USD
2021 AmerisourceBergen Corp. 1.76 1.47 USD
2020 AmerisourceBergen Corp. 1.66 1.71 USD
2019 AmerisourceBergen Corp. 1.60 1.94 USD
2018 AmerisourceBergen Corp. 1.52 1.65 USD
2017 AmerisourceBergen Corp. 1.46 1.76 USD
2016 AmerisourceBergen Corp. 1.36 1.68 USD
2015 AmerisourceBergen Corp. 1.16 1.22 USD
2014 AmerisourceBergen Corp. 0.94 1.22 USD
2013 AmerisourceBergen Corp. 0.84 1.37 USD
2012 AmerisourceBergen Corp. 0.52 1.34 USD
2012 AmerisourceBergen Corp. 0.52 1.20 USD
2011 AmerisourceBergen Corp. 0.43 1.15 USD
2010 AmerisourceBergen Corp. 0.32 1.43 USD
2010 AmerisourceBergen Corp. 0.32 1.04 USD
2009 AmerisourceBergen Corp. 0.21 0.94 USD
2008 AmerisourceBergen Corp. 0.15 0.80 USD
2007 AmerisourceBergen Corp. 0.10 0.44 USD
2006 AmerisourceBergen Corp. 0.05 0.22 USD
2005 AmerisourceBergen Corp. 0.03 0.16 USD
2004 AmerisourceBergen Corp. 0.03 0.22 USD
2003 AmerisourceBergen Corp. 0.03 0.22 USD
2002 AmerisourceBergen Corp. 0.03 0.17 USD
2001 AmerisourceBergen Corp. - - USD
2000 AmerisourceBergen Corp. - - USD
1999 AmerisourceBergen Corp. - - USD
*Yield of the Respective Date

AmerisourceBergen Corp. Calendar

Event Estimate Info Date
Earnings Report 2.813 USD Q2 2023 Earnings Release 05/03/2023
Earnings Report - Q3 2023 Earnings Release 08/03/2023
Earnings Report - Q4 2023 Earnings Release 11/02/2023
Earnings Report - Q1 2024 Earnings Release 02/01/2024

AmerisourceBergen Corp. Past Events

Event Actual EPS Info Date
Earnings Report 2.710 USD Q1 2023 Earnings Release 02/01/2023
Press Conference - - 11/03/2022
Press Conference - - 08/03/2022
Press Conference - - 05/04/2022

AmerisourceBergen Profile

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA. .

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
7
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

AmerisourceBergen Shareholder

Owner in %
Freefloat 83.02
Walgreens Boots Alliance, Inc. 16.64
Vanguard Group, Inc. (Subfiler) 9.73
State Street Corp. 3.65
JPMorgan Investment Management, Inc. 2.80
BlackRock Fund Advisors 2.57
Boston Partners Global Investors, Inc. 2.57
Vanguard Total Stock Market Index Fund 2.50
Fidelity Management & Research Co. LLC 2.30
T. Rowe Price Associates, Inc. (Investment Management) 2.06
BlackRock Institutional Trust Co. NA 1.93
Vanguard Mid Cap Index Fund 1.90
Vanguard 500 Index Fund 1.86
Geode Capital Management LLC 1.61
Bessemer Investment Management LLC 1.31
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

AmerisourceBergen Management

Name Job
Steven H. Collis Chairman, President & Chief Executive Officer
Lazarus Krikorian Chief Accounting Officer & Senior Vice President
Jennifer E. Dubas Chief Compliance Officer & Senior Vice President
James Francis Cleary Chief Financial Officer & Executive VP
Silvana Battaglia Chief Human Resources Officer & Executive VP
Elizabeth S. Campbell Chief Legal Officer & Executive Vice President
Robert P. Mauch Chief Operating Officer & Executive Vice President
Leslie E. Donato Chief Strategy Officer & Executive Vice President
Gina K. Clark EVP, Chief Communications & Administration Officer
Sun Park Executive VP & CFO-Pharmaceutical Distribution
Dennis M. Nally Independent Director
Lorence H. Kim Independent Director
Redonda G. Miller Independent Director
Lon R. Greenberg Independent Director
Richard W. Gochnauer Independent Director
D. Mark Durcan Independent Director
Kathleen W. Hyle Independent Director
Henry Wadsworth McGee Independent Director
Ornella Barra Non-Independent Director
Ann Anaya SVP, Chief Diversity Equity & Inclusion Officer
Kourosh Q. Pirouz Secretary, VP & Associate General Counsel
Bennett S. Murphy Senior Vice President-Investor Relations
Rafael Augusto Kosa Teixeira Senior Vice President-Transformation
Jack F. Quinn Treasurer & Senior Vice President